• Skip to main content
  • Skip to primary sidebar
  • Skip to footer
+49 (0) 69 / 606 278 – 0
[email protected]
Contact form
Patent- & Rechtsanwaltskanzlei

Patent- & Rechtsanwaltskanzlei

  • Deutsch

+49 (0) 69 / 606 278 – 0

  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • xing
  • Email
MENUMENU
  • Services
    • Advice On Protective IP Rights
    • Patent Application /TM Registration
    • Enforcement Of IP Rights
    • Defence Against IP Rights Enforcement
    • Costs
  • Company
    • Fields of Law
      • Patent Law
      • Utility Model Law
      • Employees’ Inventions
      • Trademark Law
      • Design Law
      • Trademark and Product Piracy
      • Expert Opinions
    • Our Law Firm
      • Dr. Karl-Hermann Meyer-Dulheuer
      • Dr. Tim Meyer-Dulheuer
      • Dr. Klaus Zimmermann
      • Zhichao Ying
      • Clara Elinor Grünewald
    • Commitment
  • Contact
    • Where To Find Us
    • Write us!
    • Request call back
  • Blog

Neologism ViruProtect descriptive: Trademark protection refused

12. February 2020

The trademark protection for the Union word mark ViruProtect was rejected before the European Court. Like the EUIPO, the court regarded the word creation ViruProtect as descriptive. The focus was on the question whether consumers would equate Viru with virus – and to what extent a new word creation is descriptive.

Public interest against trademark registration

Virus Protect

The applicant for the Union word mark ViruProtect and applicant for the trademark was the pharmaceutical manufacturer Stada Arzneimittel AG (Germany). Stada had appealed against the decision of the Board of Appeal. The Board of Appeal had considered the mark in dispute to be descriptive, since the mark ViruProtect was descriptive of the protective function against viruses against the goods covered by the mark in Nice Class 5.
Stada argued that the contested decision did not indicate why ‘Viru’ in combination with ‘Protect’ should not be monopolised on the basis of considerations of the public interest.

However, the European Court (Court of Justice of the European Union (CJEU)) made it clear in its yesterday’s judgement that that objection was irrelevant. Since the Board of Appeal had found that the mark applied for was descriptive, there was an immediate public interest in not registering the sign as a trade mark, the CJEU held.

Signs or indications which may serve to designate characteristics of the goods or services applied for should be freely available to all (Article 7(1)(c) of Regulation No 207/2009). This applies to indications of the kind, quality, quantity, intended purpose, value, geographical origin or the time of production of the goods or services claimed. In particular, so-called generic terms, which stand for a variety of more specific term contents and meanings, should be kept free.

Equating virus with viru?

The focus before the CJEU was therefore also on the question of whether consumers would equate viru with virus. The Board of Appeal had stated in the grounds of its decision that consumers would immediately and without further thought equate the element “viru” of the disputed mark with “virus”.

The Court now confirmed that assessment. The Board of Appeal correctly added that the difference between the term ‘VirusProtect’ and the sign ViruProtect was not significant either visually or phonetically and that the different spelling of the word ‘virus’ had no influence on the possible conceptual content. The CJEU agreed with this and added that divergent spellings do not remove a ground for refusal under Article 7(1)(b). c of Regulation 207/2009.

Consumers break down neologism into its constituent parts

Although consumers regularly perceive a mark as a whole, they will nevertheless break a word sign down into those word elements which give it a concrete meaning, the CJEU explained. Therefore, in the context of the goods covered by the mark applied for, consumers would tend to read the word ‘virus’ instead of ‘viru’. Consumers interpret a word sign by reference to the definitions of the words of which it is composed, which necessarily implies elements other than the word or words in question. Moreover, as regards phonetic perception, any phonetic difference resulting from the omission of the letter ‘s’ would be marginal, so that the consumer would not perceive the term ‘viru’ as a term separate from ‘virus’, but at most as a variant thereof. All the more so since virus is a generic term, as the Court made clear.

Neologism may also be descriptive

A mark consisting of a neologism may also be descriptive, the CJEU held, where it consists of elements descriptive of characteristics of the goods or services claimed. Moreover, a word mark is descriptive if at least one of its possible meanings designates a characteristic of the goods or services in question, the Court added.

Only if there is a perceptible difference between the neologism and the sum of its parts is there no descriptive character, the CJEU added. However, this requires that, because of the unusual nature of the combination in relation to the goods or services, the neologism must create an impression which is sufficiently far removed from that produced by the mere combination of meanings lent by the elements of which it is composed. The Court stated that the analysis of the relevant lexical and grammatical rules was also important in that regard.

ViruProtect follows English grammar

However, this is not the case for the mark in dispute. In its decision, the Board of Appeal correctly stated that the combination of the word elements was not unusual and that it followed the grammar rules of the English language, the CJEU stated. Despite the different spelling due to the absence of the letter ‘s’ at the end of the word ‘virus’, consumers would immediately grasp its meaning.

In the light of the foregoing, the Board of Appeal was entitled to consider that the relevant public would attribute the meaning ‘virus’ to the mark applied for, the European Court upheld the contested decision and dismissed Stada’s action. The neologism ViruProtect is descriptive of the goods claimed.

Do you also wish to protect your trademark or brand?

Our lawyers have many years of expertise in trademark law as well as in the entire field of intellectual property and are entitled to represent you in any court – in Germany and internationally.
Please contact us if you are interested.


 

Sources:

Judgement of CJEU “ViruProtect”, EU:T:2020:44

Image:

monoar | pixabay | CCO License

 

  • share  17 
  • share 
  • share 
  • tweet  
  • share 

Category iconHealthcare & Lifesciences,  Trademark Law Tag iconword mark,  descriptive,  word creation,  trademark protection,  Union word mark,  Trademark Application,  generic term,  ViruProtect,  Stada,  Virus,  combination of the word elements,  different spelling,  Neologism,  Equating

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

More articles about: Healthcare & Lifesciences

All articles

Blog Menu

  • Design Law
  • Healthcare & Lifesciences
  • International Intellectual Property
  • Licenses
  • News from our law firm
  • Overall
  • Patent Law
  • Product- and Trademark piracy
  • Trademark Law
This form uses Google Recaptcha.

You must accept cookies from Google recaptcha to use this form.

More information can be found in our privacy policy.

load form

Recent Posts

  • Bacardi wins in trademark dispute Vodka 42 BELOW 20. January 2021
  • HALLOUMI vs. BBQLOUMI: Cyprus loses again in trademark dispute 20. January 2021
  • Short word marks and similarity: First letter is not everything 19. January 2021
  • Where in Europe is a patent application worthwhile? 18. January 2021

Fields of Law

  • Patent Law
  • Utility Model Law
  • Employees’ Inventions
  • Trademark Law
  • Design Law
  • Trademark and Product Piracy
  • Expert Opinions
  • Costs

Das könnte Sie auch interessieren:

20. January 2021
Bacardi wins in trademark dispute Vodka 42 BELOW

Bacardi wins in trademark dispute Vodka 42 BELOW

20. January 2021
HALLOUMI vs. BBQLOUMI: Cyprus loses again in trademark dispute

HALLOUMI vs. BBQLOUMI: Cyprus loses again in trademark dispute

19. January 2021
Short word marks and similarity: First letter is not everything

Short word marks and similarity: First letter is not everything

15. January 2021
HOTTINGER vs. HOTTINGUER: trademark dispute over financial services

HOTTINGER vs. HOTTINGUER: trademark dispute over financial services

12. January 2021
US Trademark Law Modernized (TMA): Faster and Better for Trademark Challenges

US Trademark Law Modernized (TMA): Faster and Better for Trademark Challenges

7. January 2021
Nice Classification 2021: Robots, Joysticks and Automation

Nice Classification 2021: Robots, Joysticks and Automation

Footer

Contact

Franklinstr. 61-63
D-60486 Frankfurt am Main
Germany

+49 (0) 69 / 606 278 – 0
+49 (0) 69 / 606 278 – 199
[email protected]

Customer Reviews

Meyer-Dulheuer MD Legal Patentanwälte PartG mbB Patentrecht, Markenrecht, Eigentum hat 4,78 von 5 Sternen 23 Bewertungen auf ProvenExpert.com

Fields of Law

  • Patent Law
  • Utility Model Law
  • Employees’ Inventions
  • Trademark Law
  • Design Law
  • Trademark and Product Piracy
  • Expert Opinions
  • Costs

Law Firm

  • Request non-binding call back
  • Info secure emails
  • Company
  • Our Law Firm
  • ISO Certificate
  • Privacy Policy
  • Data handling for clients
  • Imprint

Follow Us

  • Facebook
  • Twitter
  • Google+
  • LinkedIn
  • xing
  • Email

Newsletter Signup

This form uses Google Recaptcha.

You must accept cookies from Google recaptcha to use this form.

More information can be found in our privacy policy.

load form

© Patent- & Rechtsanwaltskanzlei Meyer-Dulheuer MD Legal Patentanwälte PartG mbB

Kontaktformular

 

Rufen Sie uns an, schicken Sie uns eine Mail oder füllen Sie das Kontaktformular aus.

+49 (0) 69 / 606 278 – 0
[email protected]

This form uses Google Recaptcha.

You must accept cookies from Google recaptcha to use this form.

More information can be found in our privacy policy.

load form

Contact Form

 

Give us a call, send us an email or fill out the contact form.

+49 (0) 69 / 606 278 – 0
[email protected]

This form uses Google Recaptcha.

You must accept cookies from Google recaptcha to use this form.

More information can be found in our privacy policy.

load form